Folger Nolan Fleming Douglas Capital Management Inc. acquired a new position in Cigna Group (NYSE:CI) during the first quarter, purchasing 3,521 shares valued at approximately $939,000. Other institutional investors also adjusted their stakes, with Brighton Jones LLC increasing its position by 9.3% to own 3,736...
Cigna Corp. (CI) reported first-quarter earnings of $1.18 billion, translating to a profit of $3.68 per share. On an adjusted basis that excludes non-recurring costs and amortization, the company achieved $6.01 per share in earnings. These financial results significantly exceeded Wall Street expectations. Analysts surveyed...
The Cigna Group (NYSE: CI) is a major player in the healthcare sector with a market capitalization of $73.88 billion. Currently trading at $279.27, the stock has dipped slightly but maintains resilience within its 52-week range of $244.41 to $334.39. Analysts project an average target...
Health insurers rallied on Thursday afternoon following a wave of bullish analyst notes highlighting softer medical cost trends and potential AI efficiency gains in the managed-care sector. Humana led the advance with a 6% jump to $348, while UnitedHealth Group rose 5% to $396 and...
Cigna Group is launching 'SureFit Plus,' a new employer-focused health plan designed to lower costs by trading broad provider choice for a tighter, network-centric model. Targeted at cost-conscious midsize and large employers in select US markets, this product utilizes local collaborative-care strategies that combine narrow...
Cigna Group (CI) is a large-cap US health insurer and managed care provider offering exposure to commercial medical insurance, government health plans, and pharmacy benefits management. The company operates through two primary segments: Cigna Healthcare, which focuses on US commercial and Medicare coverage, and Evernorth,...
Cigna and UC Health are engaged in contract negotiations with a July 1 deadline for patient coverage in the Sacramento area. UC Davis Health is requesting higher payment rates from Cigna to address rising costs, including inflation, medical supply expenses, maintenance, and competitive wages for...
Zacks Equity Research released an industry outlook on June 4, 2026, highlighting five major Health Maintenance Organization (HMO) stocks: UnitedHealth Group (UNH), The Cigna Group (CI), Humana (HUM), Centene (CNC), and Molina Healthcare (MOH). The analysis identifies four key trends shaping the HMO industry: diversified...
Cigna is discontinuing coverage for GLP-1 obesity drugs, including Wegovy and Zepbound, for its own employees starting July 1, 2026. The insurer cites the availability of alternative weight-management options as the primary reason for this decision, though the underlying driver is the high cost of...
CI Global Asset Management (CI GAM) announced name changes for 37 mutual funds and ETFs previously managed by Invesco Canada Ltd., effective on or about July 31, 2026, following the acquisition of management agreements for 98 Invesco Canada funds completed the day prior. The rebranding...
The Cigna Group (CI) shares on the New York Stock Exchange are currently trading in the high USD 280s, significantly below the consensus analyst price target of approximately USD 339.50. As of May 28, 2026, major brokerages maintain a 'Moderate Buy' stance, suggesting the stock...
MJH Life Sciences has been awarded the 2025 gold-level Cigna Healthy Workforce Designation for its commitment to employee well-being and vitality. The recognition, announced on May 27, 2026, highlights MJH's successful implementation of a comprehensive workplace well-being program that aligns with Cigna Healthcare's standards for...
Cigna has officially ended negotiations to acquire rival Humana after the two companies failed to reach an agreement on price. A combination of the two insurers would have formed a entity valued at over $140 billion, creating significant scale to compete with larger players like...
Cigna Group (CI) is positioned for growth driven by strong segmental performance, improved operating efficiency, and shareholder-friendly initiatives. The company's shares have gained 7.2% year to date, underperforming the industry average of 20.1%, though its forward P/E ratio of 9.35x remains lower than the industry...
The Cigna Group reported strong financial results for the first quarter of 2026, driven by a diversified portfolio that included growth across its healthcare services and pharmacy benefit segments. Total revenues for the quarter increased 5% year-over-year to reach $68.5 billion, compared to the previous...
The Cigna Group (NYSE:CI) reported first-quarter results that led its shares to rise 2.6% to close at US$283, with statutory earnings of US$6.26 per share meeting analyst expectations and revenues of US$68 billion coming in 3.5% ahead of forecasts. Following the report, 17 analysts updated...
Cigna (CI) reported its Q1 2026 earnings results on May 1, highlighting strong revenue growth, a raised full-year earnings per share outlook, and momentum in its core healthcare and specialty businesses. The company posted consolidated revenue of $68.5 billion for the quarter, with adjusted EPS...
Cigna Group (CI) reported strong first-quarter 2026 results, delivering consolidated revenue of $68.5 billion and adjusted EPS of $7.79, which reflects a 16% year-over-year increase. On the back of this performance, management raised its full-year 2026 adjusted EPS guidance to at least $30.35 per share....
Cigna Group (CI) reported first-quarter 2026 results that exceeded analyst expectations, driven primarily by strong performance from its Evernorth Health Services segment. The company posted adjusted earnings per share of $7.79, surpassing the Zacks Consensus Estimate by 2.2%, with total adjusted EPS growth of 15.6%...
The Cigna Group (CI) released its First Quarter 2026 earnings call transcript on April 30, 2026, with executives David Cordani (CEO & Chair), Brian Evanko (President & COO), and Ann Dennison (CFO) participating. The company is currently reviewing its financial results for the quarter and...
